» Articles » PMID: 30396981

The Potential Use of a Ketogenic Diet in Pancreatobiliary Cancer Patients After Pancreatectomy

Overview
Journal Anticancer Res
Specialty Oncology
Date 2018 Nov 7
PMID 30396981
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aim: High-carbohydrate diets are generally provided to post-pancreatectomy cancer patients. Low energy density of this diet may obstruct proper energy intake and recovery. This study aimed to assess the effects of high-fat, high-energy ketogenic diet (KD) in these patients.

Patients And Methods: After pancreatectomy, 9 patients were provided with general diet (GD) while 10 were served KD. Meal compliance, energy intake rate, meal satisfaction and presence of complications were monitored throughout hospital stay. Data on nutritional status, serum lipids and body composition were collected and compared between groups.

Results: Meal compliance, energy intake rate and meal satisfaction score were higher in KD. There were no differences in complications, nutritional status and serum lipids. The decrease in body cell mass (BCM) was greater in GD.

Conclusion: Post-pancreatectomy cancer patients who consumed KD had a higher energy intake and BCM. These results suggest the potential use of KD as an adjuvant anti-cancer therapy.

Citing Articles

Therapeutic potential of β-hydroxybutyrate in the management of pancreatic neoplasms: exploring novel diagnostic and treatment strategies.

Vaezi M, Nekoufar S, Robati A, Salimi V, Tavakoli-Yaraki M Lipids Health Dis. 2024; 23(1):376.

PMID: 39543582 PMC: 11562866. DOI: 10.1186/s12944-024-02368-7.


Pharmacomicrobiomics in precision cancer therapy: bench to bedside.

Le Ngoc K, Pham T, Nguyen T, Huong P Front Immunol. 2024; 15:1428420.

PMID: 39315107 PMC: 11416994. DOI: 10.3389/fimmu.2024.1428420.


A long journey to treat epilepsy with the gut microbiota.

Li Q, Gu Y, Liang J, Yang Z, Qin J Front Cell Neurosci. 2024; 18:1386205.

PMID: 38988662 PMC: 11233807. DOI: 10.3389/fncel.2024.1386205.


Feasibility and metabolic outcomes of a well-formulated ketogenic diet as an adjuvant therapeutic intervention for women with stage IV metastatic breast cancer: The Keto-CARE trial.

Buga A, Harper D, Sapper T, Hyde P, Fell B, Dickerson R PLoS One. 2024; 19(1):e0296523.

PMID: 38166036 PMC: 10760925. DOI: 10.1371/journal.pone.0296523.


Ketogenic Diet and Multiple Health Outcomes: An Umbrella Review of Meta-Analysis.

Chen S, Su X, Feng Y, Li R, Liao M, Fan L Nutrients. 2023; 15(19).

PMID: 37836444 PMC: 10574428. DOI: 10.3390/nu15194161.